FCM
GCVRZ
Farallon Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,195,584
| Closed | -$7.91M | – | 133 |
|
|
2019
Q4 | $7.91M | Buy |
9,195,584
+2,367,779
| +35% | +$2.04M | 0.05% | 98 |
|
|
2019
Q3 | $3.89M | Hold |
6,827,805
| – | – | 0.03% | 90 |
|
|
2019
Q2 | $3.55M | Hold |
6,827,805
| – | – | 0.02% | 95 |
|
|
2019
Q1 | $3.07M | Hold |
6,827,805
| – | – | 0.02% | 88 |
|
|
2018
Q4 | $3.28M | Hold |
6,827,805
| – | – | 0.02% | 87 |
|
|
2018
Q3 | $3.82M | Hold |
6,827,805
| – | – | 0.02% | 93 |
|
|
2018
Q2 | $3.41M | Hold |
6,827,805
| – | – | 0.02% | 85 |
|
|
2018
Q1 | $2.89M | Hold |
6,827,805
| – | – | 0.02% | 83 |
|
|
2017
Q4 | $2.6M | Hold |
6,827,805
| – | – | 0.02% | 78 |
|
|
2017
Q3 | $2.46M | Hold |
6,827,805
| – | – | 0.02% | 80 |
|
|
2017
Q2 | $2.6M | Hold |
6,827,805
| – | – | 0.03% | 76 |
|
|
2017
Q1 | $3.07M | Hold |
6,827,805
| – | – | 0.03% | 67 |
|
|
2016
Q4 | $2.6M | Buy |
6,827,805
+4,000,000
| +141% | +$1.52M | 0.03% | 65 |
|
|
2016
Q3 | $764K | Buy |
2,827,805
+33,000
| +1% | +$8.92K | 0.01% | 65 |
|
|
2016
Q2 | $671K | Buy |
2,794,805
+2,546,110
| +1,024% | +$611K | 0.01% | 61 |
|
|
2016
Q1 | $28K | Buy |
+248,695
| New | +$28K | ﹤0.01% | 70 |
|
|
2013
Q3 | – | Sell |
-1,320,000
| Closed | -$2.51M | – | 101 |
|
|
2013
Q2 | $2.51M | Buy |
+1,320,000
| New | +$2.51M | 0.05% | 74 |
|